AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V902. A total of 5 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $377 | -99.9% | 87,300 | 0.0% | 0.00% | – |
| Q3 2022 | $656,000 | -25.2% | 87,300 | 0.0% | 0.00% | – |
| Q2 2022 | $877,000 | -18.9% | 87,300 | 0.0% | 0.00% | – |
| Q1 2022 | $1,081,000 | -65.5% | 87,300 | -36.2% | 0.00% | – |
| Q4 2021 | $3,131,000 | +890.8% | 136,900 | +173.8% | 0.00% | – |
| Q2 2019 | $316,000 | -2.8% | 50,000 | 0.0% | 0.00% | – |
| Q1 2019 | $325,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 377,600 | $3,795,000 | 0.01% |
| JANE STREET GROUP, LLC | 668,800 | $6,721,000 | 0.00% |
| SIMPLEX TRADING, LLC | 274,100 | $2,754,000 | 0.00% |
| JPMORGAN CHASE & CO | 87,300 | $877,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |